GHK-Cus anti-inflammatory effect does not translate into measurable fat loss in our patient population
As your gastrointestinal tract interacts with the delayed stomach-emptying properties of the molecule, you will likely notice typical brief updates, which are standardly mild and tend to fade after a few weeks of consistent use : Gastrointestinal Shifts: Highly common, including mild nausea, brief vomiting, diarrhea, stomach bloating, gas, indigestion, or temporary constipation
More weight loss at 10 mg than 5 mg, and more at 15 mg than 10 mg
With the safe, proven support of GLPs, achieving your goals becomes more attainable
However, like any medical treatment, its essential to make informed decisions based on professional guidance and your individual health needs
Patients with anaplastic thyroid cancer should have molecular testing for a mutation in the BRAF gene